Zentiva Advocates for Reforms in Urban Wastewater Treatment
As Europe faces mounting global challenges, including geopolitical tensions and evolving regulations, the call for a reassessment of the Urban Wastewater Treatment Directive (UWWTD) is growing louder. At a recent gathering in Brussels, policymakers, industry leaders, and stakeholders came together to discuss critical shifts needed within the healthcare landscape. The conference emphasized the importance of creating a resilient health union that prioritizes both environmental sustainability and access to necessary medicines.
The Importance of a Balanced Approach
The focal theme of the meeting was "Building a Resilient Health Union: Security, Access and Competitiveness." Participants shed light on pressing issues surrounding the implementation of the UWWTD, alongside discussions on advancing the Critical Medicines Act and embracing digital and biotechnological innovations. These deliberations are vital for ensuring that Europe can maintain medicine availability while responsibly transitioning to sustainable practices.
CEO's Insights on the Clean Transition
Steffen Saltofte, CEO of Zentiva, actively participated in a panel about delivering access to medicines during the clean transition era. His remarks underscored the necessity of aligning environmental goals with the health sector's need for sustainable and affordable medication. Representing perspectives from Germany and the Czech Republic, Saltofte explained the real impacts of current legislative measures on the generics industry.
Urgency for Reform: Pause, Repair, Relaunch
The current state of the UWWTD poses considerable risks to medicine accessibility and long-term sustainability, according to Zentiva. Unrealistic assessments and cost projections from the European Commission raise alarms about the future availability of essential off-patent medications throughout Europe. As the company advocates for a decisive pause and a relaunch of the directive, they stress three significant messages.
Key Messages from Zentiva
Firstly, the current implementation strategies threaten to impair medicine affordability, supply security, and long-term sustainability. Secondly, they propose studying the Swiss model as a viable alternative. This approach showcases how fair cost-sharing and phased implementation can achieve environmental goals while supporting patient care.
Protecting the Future of Medicines in Europe
Zentiva also emphasizes the need to protect the economic viability of medicines produced within Europe. If imposing environmental regulations continue to exert undue financial pressure on manufacturers, the risk of production moving out of Europe looms large. Such a scenario would undermine both supply resilience and the EU's healthcare strategic autonomy.
Striking a Balance Between Sustainability and Access
In conclusion, Saltofte highlighted that sustainability encompasses more than just environmental factors; it also involves ensuring equitable healthcare access for all. The quest for solutions that prioritize both environmental responsibility and the affordability of medicines is essential. By re-envisioning legislation and supporting industry needs, the goal of health as a universal right can be achieved.
About Zentiva
Zentiva is dedicated to enhancing health and well-being for generations to come. Operating across Europe, the company develops and delivers high-quality, affordable medicines to over 100 million individuals in more than 30 countries. With four wholly-owned manufacturing plants and a robust external manufacturing partner network, Zentiva ensures consistent supply security. At its core, Zentiva believes in fostering a dynamic workplace where over 5,000 employees contribute their talents toward the common goal of health access for everyone.
A Commitment to a Sustainable Future
With origins tracing back over 500 years to a historic pharmacy in Prague, Zentiva is committed to acting today to secure a sustainable tomorrow for future generations, ensuring that quality healthcare remains accessible for many years ahead.
Frequently Asked Questions
1. What is the Urban Wastewater Treatment Directive (UWWTD)?
The UWWTD is a European legislative framework designed to ensure that urban wastewater is treated properly before being discharged into the environment, protecting both health and ecosystems.
2. Why is Zentiva calling for a Pause - Repair - Relaunch of the UWWTD?
Zentiva argues that the current implementation of the UWWTD threatens medicine affordability and supply security, necessitating a reevaluation of its provisions.
3. What alternative does Zentiva propose regarding the UWWTD?
Zentiva advocates for the Swiss model, which promotes fair cost-sharing and collaboration among sectors to achieve environmental objectives without hindering access to healthcare.
4. How does Zentiva support sustainable healthcare?
Zentiva works towards maintaining the economic viability of medicine production in Europe while advocating for sustainable practices that ensure access to quality healthcare.
5. What is the future vision of Zentiva?
Zentiva aims to continue providing access to affordable medicines while fostering a workplace culture that encourages inclusion, innovation, and excellence.
